Mohammad Abdel‐Halim
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Organic Chemistry top 10%
- Synthesis and biological activity
Papers in
-
- Phosphodiesterase function and regulation 12
- Phenothiazines and Benzothiazines Synthesis and Activities 7
- Histone Deacetylase Inhibitors Research 6
- Protein Kinase Regulation and GTPase Signaling 6
- Cancer therapeutics and mechanisms 5
- 14-3-3 protein interactions 5
-
- Synthesis and biological activity 11
- Co-authors
- Alireza Abadi (49 shared papers)Matthias Engel (38 shared papers)Ahmed K. ElHady (16 shared papers)Samar Mansour (11 shared papers)Rania M. Hathout (3 shared papers)Gary A. Piazza (13 shared papers)Heba Handoussa (5 shared papers)Rasha M. El Nashar (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (11 papers)Bioorganic Chemistry (10 papers)Journal of Medicinal Chemistry (4 papers)Archiv der Pharmazie (4 papers)Molecules (3 papers)
- Partner nations
- EgyptGermanyUnited States
In The Last Decade
Mohammad Abdel‐Halim
77 papers receiving 883 citations
Peers
Comparison fields: 5 of 100
- Pharmaceutical Science 62
- Organic Chemistry 231
- Pharmacology 133
- Toxicology 24
- Analytical Chemistry 66
Countries citing papers authored by Mohammad Abdel‐Halim
This map shows the geographic impact of Mohammad Abdel‐Halim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Abdel‐Halim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Abdel‐Halim more than expected).
Fields of papers citing papers by Mohammad Abdel‐Halim
This network shows the impact of papers produced by Mohammad Abdel‐Halim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Abdel‐Halim. The network helps show where Mohammad Abdel‐Halim may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Abdel‐Halim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 57 | |
| 2 | 2018 | 50 | |
| 3 | 2018 | 47 | |
| 4 | 2017 | 43 | |
| 5 | 2010 | 41 | |
| 6 | 2014 | 35 | |
| 7 | 2023 | 31 | |
| 8 | 2023 | 27 | |
| 9 | 2021 | 27 | |
| 10 | 2020 | 25 | |
| 11 | 2022 | 24 | |
| 12 | 2020 | 24 | |
| 13 | 2022 | 23 | |
| 14 | 2018 | 22 | |
| 15 | 2019 | 21 | |
| 16 | 2021 | 20 | |
| 17 | 2021 | 20 | |
| 18 | 2021 | 19 | |
| 19 | 2021 | 19 | |
| 20 | 2018 | 18 |
About Mohammad Abdel‐Halim
Mohammad Abdel‐Halim is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Oncology and Immunology, having authored 82 papers that have together received 895 indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (12 papers), Synthesis and biological activity (11 papers), Cholinesterase and Neurodegenerative Diseases (10 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Cancer therapeutics and mechanisms (5 papers) and 14-3-3 protein interactions (5 papers). The work is most often cited by research in Pharmaceutical Science (62 citations), Organic Chemistry (231 citations), Pharmacology (133 citations), Toxicology (24 citations) and Analytical Chemistry (66 citations). Mohammad Abdel‐Halim has collaborated with scholars based in Egypt, Germany and United States. Frequent co-authors include Alireza Abadi, Matthias Engel, Ahmed K. ElHady, Samar Mansour, Rania M. Hathout, Gary A. Piazza, Heba Handoussa, Rasha M. El Nashar, Salma N. Tammam and Rolf W. Hartmann. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic Chemistry, Journal of Medicinal Chemistry, Archiv der Pharmazie and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.